Neurocrine Biosciences shares owned by DSM Capital Partners
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by DSM Capital Partners
from 13F filings
Historical chart of DSM Capital Partners investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by DSM Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by DSM Capital Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $161M | 1.2M | 131.76 |
| 2023-09-30 | $138M | 1.2M | 112.50 |
| 2023-06-30 | $100M | 1.1M | 94.30 |
| 2023-03-31 | $128M | 1.3M | 101.22 |
| 2022-12-31 | $159M | 1.3M | 119.44 |
| 2022-09-30 | $140M | 1.3M | 106.21 |
| 2022-06-30 | $130M | 1.3M | 97.48 |
| 2022-03-31 | $127M | 1.4M | 93.75 |
| 2021-12-31 | $120M | 1.4M | 85.17 |
| 2021-09-30 | $146M | 1.5M | 96.15 |
| 2021-06-30 | $149M | 1.5M | 97.32 |
| 2021-03-31 | $131M | 1.3M | 97.25 |
| 2020-12-31 | $107M | 1.1M | 95.85 |
| 2020-09-30 | $81M | 837k | 96.16 |
| 2020-06-30 | $106M | 866k | 122.00 |
| 2020-03-31 | $74M | 860k | 86.55 |
| 2019-12-31 | $72M | 671k | 107.49 |
| 2019-09-30 | $59M | 651k | 90.11 |
| 2019-06-30 | $56M | 661k | 84.43 |
| 2019-03-31 | $61M | 696k | 88.10 |